Coventry Apprentice star comes to the defense of hospital pharmacy under fire
The Coventry star of The Apprentice 2022 has jumped to the pharmacy’s defense under fire from Coventry and Warwickshire University Hospitals.
Earlier in the week, CoventryLive reported how Lloyds Pharmacy for hospital outpatients was squarely beaten by critics, with the outlet only scoring 1.3 out of a possible 5 stars on Google.
Around the time the article was written, a man took to Google Review to show his support for the chemist with a glowing 5-star review.
Read more news about Coventry
Harry Mahmood, who was eliminated first in this season’s series of long-running BBC show The Apprentice, couldn’t speak highly of the pharmacy.
Her review reads: “I have been here several times with my family and honestly by far the best care, support and professionalism I have ever experienced.
“It’s a testament to management and staff coming together to support the entire community. Keep up the great work, keep shining.”
The notice was signed “Harry Mahmood BEM Apprentice candidate 2022”.
Harry, who received a British Empire Medal (BEM) in the 2021 New Years Honors List, said his aim was for him and Lord Sugar to become “the bad boys of the bath bomb world together”.
But sadly, Lord Sugar got rid of Harry much faster than this chemist supposedly dispenses a prescription, and he was voted first on the show last month.
Responding to negative reviews, a spokesperson for Lloyds Pharmacy previously said: “LloydsPharmacy at the University Hospital of Coventry and Warwickshire is an outpatient pharmacy dispensary (OPD) providing specialist pharmaceutical care to outpatients in the hospital. , dispensing tens of thousands of prescription drugs each year.
“Our priority is to provide the best possible service to our patients. Complex processes are in place at the Ambulatory Pharmacy to ensure the safe delivery of medications, and we work with our patients to provide the most convenient way to access medications. that they need. .”
Keep up to date with the latest news with our email alerts straight to your inbox. Register here.